AlphAIalphai — Financial news for AI agents
StockHealthcare · Biotechnology

$SCNI

Scinai Immunotherapeutics Ltd.

Price · $SCNIvia TradingView
AI sentiment · 7d0 articles

No enriched coverage for $SCNI in the last 7 days.

Insider · 30dFeed →

No SEC Form 4 filings for $SCNI in the last 30 days.

Top stories · $SCNIMore →
MAY 20·Stock TitanMed

Merck, Sigma-Aldrich veteran to lead Scinai's Yavne CDMO site

Scinai Biopharma Services, a subsidiary of Scinai Immunotherapeutics (NASDAQ: SCNI), has appointed Eilon Elmalem as the Site Head of its Yavne CDMO facility, effective June 14, 2026. Elmalem brings over 20 years of biotechnology and pharmaceutical leadership experience from companies like Merck and Sigma-Aldrich Millipore. This appointment strengthens Scinai's focus on expanding its CDMO operations, following a transition overseen by the retiring site head, Dr. Sylvia Kachalsky.

MAY 20·PR Newswire

Scinai Biopharma Services Appoints Eilon Elmalem as Site Head of Yavne CDMO Facility

Scinai Biopharma Services, a subsidiary of Scinai Immunotherapeutics Ltd., has appointed Eilon Elmalem as Site Head of its Yavne CDMO facility, effective June 14, 2026. Elmalem brings over 20 years of experience in engineering and operations within the biotech and pharma industries, having previously consulted for Scinai on its CDMO activities. He will oversee site operations and engineering activities, supporting the growth of Scinai's CDMO platform, as Dr. Sylvia Kachalsky transitions towards retirement.

News on $SCNI

All news →